Encontrado 1 documento, a visualizar página 1 de 1
Ordenado por
Data
ir para a página:
1
Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comp...
Jarimba, Roberto Saldanha; Eliseu, Miguel Nobre; Pedroso Lima, João; Quaresma, Vasco; Moreira, Pedro; Nunes, Pedro Coelho; Silva, Edgar Tavares daProstate cancer is the most common cancer in men, accounting for 15% of all diagnosed cancers and is the sixth leading cause of cancerrelated deaths amongst men worldwide. Abiraterone and enzalutamide were the first two novel hormonal agents approved for the treatment of metastatic prostate cancer but there is a lack of quality evidence regarding which is associated with better outcomes and who would benefit th...
Data: 2021
|
Origem: Estudo Geral - Universidade de Coimbra